Media coverage
1Media coverage
Title Expert Discusses Durvalumab and Future of Immunotherapy in NSCLC Media name/outlet OncLive Country United States Date 10/28/18 Persons Neil Morganstein
Press/Media: Press / Media
Media coverage
Title | Expert Discusses Durvalumab and Future of Immunotherapy in NSCLC |
---|---|
Media name/outlet | OncLive |
Country | United States |
Date | 10/28/18 |
Persons | Neil Morganstein |